Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Update on microchipping and adverse reactions
Dr Sally Everitt
Dr Sally Everitt, BSAVA's scientific policy advisor updated delegates on the new regulations at BSAVA Congress.
Vets must now report adverse reactions to the VMD

Kick-starting the Big Issues stream at BSAVA Congress 2016 this morning, Dr Sally Everitt, BSAVA's scientific policy advisor, and Dr Giles Davis from the VMD, updated delegates on microchipping and adverse reactions.

From 6 April 2016, microchipping of dogs over the age of eight weeks became compulsory throughout the UK.

Not much has changed in terms of who can microchip a dog. Microchips can be implanted by a veterinary surgeon or a registered veterinary nurse under of the direction of a veterinary surgeon.  A student vet or a student veterinary nurse may also implant microchips under the direction of a veterinary surgeon.

Exemption certificates may be issued for the following, because it would seriously adversely affect the dog's health or significantly compromise the dog's health:

  • Size of dog
  • Severe illness
  • Infection, injury or adverse reaction at site of microchipping
  • Abnormalities of blood clotting
  • Behavioural concerns

There are different certificates for England and Wales, but no certificate for Scotland. However, headed notepaper signed by the vet certifying the dog should not be microchipped will suffice.

Adverse reactions

Under the new microchipping regulations, veterinary practitioners must report any adverse reactions to a microchip - or failure of a microchip - to the Veterinary Medicines Database (VMD).

Migration from the site of implantation is now classed as an adverse event. However, as there is no requirement to record the site of microchip implantation on the animal’s record or microchip database, actual migration – as opposed to incorrect placement at initial implantation – is difficult to ascertain.

For this reason the BSAVA recommend that, unless the veterinary surgeon has more detailed evidence on implantation site, microchips located within the red area of the diagram found at www.bsava.com, do not need to be reported as having migrated.  

Animals with a failed microchip will need to have a new one unless it qualifies for exemption. More information about this can be found on the BSAVA website.

Mr Davis concluded the meeting with an overview of the VMD's annual report on adverse reactions, which is due to be published later this year.

Since reporting became mandatory in February 2015, the VMD have recieved 1420 reports of adverse reactions. Five per cent of these were migrations, 45 per cent were failures, while just four per cent were for reactions.

Some of the most common reported signs were swelling, movement of implant, and implant site infection. The reports mainly came from England and were largely for dogs, however the scheme is available for all species.

For more information on adverse reactions, or to report an adverse event, visit https://www.gov.uk/government/organisations/veterinary-medicines-directorate

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.